Journals / E Journal of Cardiovascular Medicine / 2020 / Cilt: 8 - Sayı: 2

The Obesity Paradox Existing in Idiopathic Pulmonary Arterial Hypertension

Pages
78–84
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: BMI seems to be linearly but inversely related to all-cause mortality among patients with idiopathic PAH.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Our purpose was to evaluate the association between idiopathic pulmonary arterial hypertension (PAH) and obesity, as indicated by the body-mass index (BMI), in terms of the all-cause mortality in a group of patients from a specialized center.
📊
Key Findings & Data:Materials and Methods: In this study, we retrospectively analyzed 78 consecutive adult patients with idiopathic PAH.
💡
Conclusion & Impact:Conclusion: BMI seems to be linearly but inversely related to all-cause mortality among patients with idiopathic PAH.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: Our purpose was to evaluate the association between idiopathic pulmonary arterial hypertension (PAH) and obesity, as indicated by the body-mass index (BMI), in terms of the all-cause mortality in a group of patients from a specialized center. Materials and Methods: In this study, we retrospectively analyzed 78 consecutive adult patients with idiopathic PAH. The patients were classified into two groups as the deceased (D) and the survived (S). A set of data was collected for each patient, including gender, age, weight, height, BMI (kg/m2), World Health Organization functional class (WHO FC), brain natriuretic peptide (BNP), hemoglobin, the presence of atrial fibrillation (AF), 6-minute walking distance (6MWD), echocardiographic and hemodynamic parameters. Results: The mean follow-up period was 33.7 months (maximum: 128 months), 38 deaths (48.7%) were noted. The two groups were found to be similar in terms of gender, age, and the presence of AF. The median BNP level in group D was significantly higher than that in group S (p<0.001). Baseline WHO FC III-IV was significantly more common in group D than that in group S (89.5% vs 57.5%, p=0.003). Group D had significantly lower BMI and 6MWD compared to those in group S (p<0.001 and p=0.017, respectively). Multivariate logistic regression analysis showed that BMI [Odds ratio (OR)=0.632, 95% confidence interval (CI)=0.478-0.837, p=0.001] and 6MWD (OR=0.981, 95% CI=0.970-0.993, p=0.002) were independent predictors of mortality in this cohort. The receiver operating characteristic curve analysis was performed to assess the utility of BMI as a predictor of mortality. The optimal BMI cut-off was 24.25 kg/m2, with 60.5% sensitivity and 82.5% specificity (area under the curve=0.759, 95% CI=0.654-0.864, p<0.001) and thepatients with a BMI of ≤24.25 had worse prognosis based on the Kaplan Meier analysis survival curves (log-rank p<0.004). Conclusion: BMI seems to be linearly but inversely related to all-cause mortality among patients with idiopathic PAH.

🔖

Cite This Article

ŞENTÜRK, B., AKDENİZ, B., ÖZPELİT, E., YILMAZ, M. B., KAHRAMAN, B. Ö., SEZGİN, D., TERTEMİZ, K. C., SEVİNÇ, C. (2020). The Obesity Paradox Existing in Idiopathic Pulmonary Arterial Hypertension. E Journal of Cardiovascular Medicine, Cilt: 8 - Sayı: 2, 78–84. https://ajindex.com/articles/150668

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Tuder RM, Archer SL, Dorfmüller P, Erzurum SC, Guignabert C, Michelakis E, et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol 2013;62:D4-12
  2. Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, Lee A, et al. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med 2017;377:13-27
  3. Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One 2013;8:e65174
  4. Dixon AE, Holguin F, Sood A, Salome CM, Pratley RE, Beuther David A, et al. An official American Thoracic Society Workshop report: obesity and asthma. Proc Am Thorac Soc 2010;7:325-35
  5. Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. Jama 2004;291:2013-6
  6. Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37:67-119
  7. Obesity and overweight. World Health Organization 2018. https://www. who.int/news-room/fact-sheets/detail/obesity-and-overweight (Last access: 22 May 2020
  8. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol 2006;26:968-76
  9. Lainscak M, von Haehling S, Doehner W, Sarc I, Jeric T, Ziherl K, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle 2011;2:81-86
  10. Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M, ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J 2007;153:74-81
  11. Chittal P, Babu AS, Lavie CJ. Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease? COPD 2015;12:14-8
  12. Lavie CJ, Sharma A, Alpert MA, De S